Automate Your Wheel Strategy on ELV
With Tiblio's Option Bot, you can configure your own wheel strategy including ELV - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol ELV
- Rev/Share 838.1488
- Book/Share 194.2028
- PB 1.516
- Debt/Equity 0.6904
- CurrentRatio 0.0
- ROIC 29.1255
- MktCap 66101001900.0
- FreeCF/Share 17.7192
- PFCF 16.5211
- PE 12.3663
- Debt/Assets 0.2476
- DivYield 0.0228
- ROE 0.1251
- Rating B+
- Score 3
- Recommendation Neutral
- P/E Score 2
- DCF Score 5
- P/B Score 3
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Downgrade | ELV | Argus | Buy | Hold | -- | -- | July 21, 2025 |
| Downgrade | ELV | Leerink Partners | Outperform | Market Perform | -- | $310 | July 18, 2025 |
| Downgrade | ELV | Robert W. Baird | Outperform | Neutral | -- | $529 | April 15, 2025 |
| Upgrade | ELV | Argus | Hold | Buy | -- | $450 | March 17, 2025 |
| Downgrade | ELV | Stephens | Overweight | Equal Weight | $520 | $440 | Jan. 22, 2025 |
| Downgrade | ELV | Argus | Buy | Hold | -- | -- | Oct. 18, 2024 |
News
Elevance Health: CEO Buys As CareBridge Drives Strong Growth
Published: July 24, 2025 by: Seeking Alpha
Sentiment: Positive
On July 18, the CEO bought $2.4MM worth, after the sell-off following the last earnings call. Carelon Services is growing fast, supported by the December acquisition of CareBridge. The aging population, the rising interest in well-being, and the potential expansion in Florida and Texas are a ray of light in the current gloomy context of the company.
Read More
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Published: July 18, 2025 by: Zacks Investment Research
Sentiment: Positive
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Read More
Top Stock Movers Now: PepsiCo, Elevance Health, CSX, and More
Published: July 17, 2025 by: Investopedia
Sentiment: Positive
Major U.S. equities indexes were higher at midday Thursday in the wake of better-than-expected quarterly results from several major companies. The Dow, S&P 500, and Nasdaq all advanced.
Read More
Elevance Health Q2 Earnings Miss Estimates on Rising Medical Costs
Published: July 17, 2025 by: Zacks Investment Research
Sentiment: Negative
ELV's Q2 EPS slides 12.6% y/y and misses estimates as rising Medicaid and ACA costs weigh on the results.
Read More
Elevance Health, Inc. (ELV) Q2 2025 Earnings Call Transcript
Published: July 17, 2025 by: Seeking Alpha
Sentiment: Neutral
Elevance Health, Inc. (NYSE:ELV ) Q2 2025 Earnings Conference Call July 17, 2025 8:30 AM ET Company Participants Felicia Farr Norwood - Executive VP & President of Government Health Benefits Gail Koziara Boudreaux - President, CEO & Director Mark Bradley Kaye - Executive VP & CFO Morgan Kendrick - Corporate Participant Nathan Allen Rich - Vice President of Investor Relations Peter David Haytaian - Executive VP and President of Carelon & CarelonRx Conference Call Participants Albert J. William Rice - UBS Investment Bank, Research Division Andrew Mok - Barclays Bank PLC, Research Division Ann Kathleen Hynes - Mizuho Securities USA …
Read More
Elevance Stock Falls After Earnings. What It Means for UnitedHealth, Other Insurers.
Published: July 17, 2025 by: Barrons
Sentiment: Negative
The health insurer now expects 2025 earnings of just $30 a share, citing ongoing and industry-wide impact of elevated cost trends in ACA and Medicaid.
Read More
Most Managed Care Insurers Expected To See Q2 2025 Drops In Revenue, Net Income
Published: July 17, 2025 by: Seeking Alpha
Sentiment: Negative
A majority of publicly traded US health insurers are expected to post QoQ declines in revenue and net income in Q2, according to an S&P Global Market Intelligence analysis of sell-side analyst forecasts. Of the eight largest publicly traded US managed care insurers, all but two — UnitedHealth Group and Alignment Healthcare — are projected to report lower revenue compared with Q1 2025, while all eight are forecast to log higher revenue than Q2 2024. In Q2, all eight of the largest publicly traded US managed care insurers, except The Cigna Group, are expected to log lower net income sequentially, …
Read More
Elevance Health Reports Second Quarter 2025 Results
Published: July 17, 2025 by: Business Wire
Sentiment: Neutral
INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health, Inc. (NYSE: ELV) reported second quarter 2025 results. "In the second quarter, Elevance Health made meaningful progress in delivering an experience that is simple and personal to those we serve, while advancing our efforts to enhance efficiency across the healthcare system. We are updating our outlook to reflect elevated medical cost trends in ACA and slower rate alignment in Medicaid. While the external environment continues to evolve, we are foc.
Read More
Elevance Health: Much Cheaper Than UNH, Yet No Drama
Published: July 16, 2025 by: Seeking Alpha
Sentiment: Neutral
The market often misinterprets price declines as value. For Elevance Health, I see a disconnect between market cap and long-term earnings potential. Health sector valuations have dropped sharply, but lower multiples reflect uncertainty, not necessarily increased risk for robust companies like ELV. Elevance Health stands out for its ability to manage industry uncertainties and is well-positioned for a valuation re-rating as confidence returns.
Read More
Elevance to Report Q2 Earnings: Will Rising Costs Pressure Profits?
Published: July 14, 2025 by: Zacks Investment Research
Sentiment: Negative
ELV's second-quarter earnings may face pressure as rising costs and lower Medicaid memberships offset strong revenue gains.
Read More
Elevance Steps In As UnitedHealth Delays — Will It Set The Tone For Insurers?
Published: July 14, 2025 by: Benzinga
Sentiment: Neutral
Health insurer Elevance Health Inc. ELV is scheduled to release its second quarter 2025 financial results on July 17.
Read More
Eyes On Elevance Health, Not UnitedHealth, As First To Report Earnings
Published: July 14, 2025 by: Forbes
Sentiment: Neutral
For years now, UnitedHealth Group has been the first of the major health insurers to report its quarterly earnings. And Wall Street analysts and investors have looked to the healthcare giant -- which owns the nation's largest health insurer – for clues on how the sector is doing.
Read More
ELV Deadline: ELV Investors with Losses in Excess of $100K Have Opportunity to Lead Elevance Health, Inc. Securities Fraud Lawsuit
Published: July 11, 2025 by: PRNewsWire
Sentiment: Neutral
NEW YORK , July 11, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Elevance Health, Inc. (NYSE: ELV) between April 18, 2024 and October 16, 2024, both dates inclusive (the "Class Period"), of the important July 11, 2025 lead plaintiff deadline. So what: If you purchased Elevance Health common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
Read More
FINAL ELV DEADLINE ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Elevance Health, Inc. and Urgently Encourages Investors to Contact the Firm
Published: July 11, 2025 by: GlobeNewsWire
Sentiment: Neutral
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Elevance Health (ELV) To Contact Him Directly To Discuss Their Options
Read More
ELV DEADLINE TODAY: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Elevance Health, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important July 11 Deadline in Securities Class Action – ELV
Published: July 11, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, July 11, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Elevance Health, Inc. (NYSE: ELV) between April 18, 2024 and October 16, 2024, both dates inclusive (the “Class Period”), of the important July 11, 2025 lead plaintiff deadline.
Read More
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Elevance Health
Published: July 11, 2025 by: GlobeNewsWire
Sentiment: Neutral
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Elevance To Contact Him Directly To Discuss Their Options
Read More
DEADLINE TOMORROW: Berger Montague Advises Elevance Health (NYSE: ELV) Investors to Contact the Firm Before July 11, 2025
Published: July 10, 2025 by: PRNewsWire
Sentiment: Neutral
PHILADELPHIA , July 10, 2025 /PRNewswire/ -- Berger Montague PC advises investors that a securities class action lawsuit has been filed against Elevance Health, Inc. ("Elevance" or the "Company") (NYSE: ELV) on behalf of purchasers of Elevance securities between April 18, 2024 through October 16, 2024, inclusive (the "Class Period"). Investor Deadline: Investors who purchased or acquired Elevance securities during the Class Period may, no later than JULY 11, 2025 , seek to be appointed as a lead plaintiff representative of the class.
Read More
Earnings Preview: Elevance Health (ELV) Q2 Earnings Expected to Decline
Published: July 10, 2025 by: Zacks Investment Research
Sentiment: Negative
Elevance Health (ELV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Read More
Elevance Health, Inc. (ELV) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
Published: July 09, 2025 by: PRNewsWire
Sentiment: Neutral
BENSALEM, Pa. , July 9, 2025 /PRNewswire/ -- The Law Offices of Howard G.
Read More
ELV DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Elevance Health, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important July 11 Deadline in Securities Class Action – ELV
Published: July 08, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, July 08, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Elevance Health, Inc. (NYSE: ELV) between April 18, 2024 and October 16, 2024, both dates inclusive (the “Class Period”), of the important July 11, 2025 lead plaintiff deadline.
Read More
Deadline Soon: Elevance Health, Inc. (ELV) Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit
Published: July 08, 2025 by: Business Wire
Sentiment: Neutral
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz reminds investors of the upcoming July 11, 2025 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on behalf of investors who acquired Elevance Health, Inc. (“Elevance” or the “Company”) (NYSE: ELV) common stock between April 18, 2024, and October 16, 2024, inclusive (the “Class Period”). IF YOU ARE AN INVESTOR WHO LOST MONEY ON ELEVANCE HEALTH, INC. (ELV), CLICK HERE TO PARTICIPATE IN THE.
Read More
ELV Investors Have the Opportunity to Lead the Elevance Health Securities Fraud Lawsuit with Faruqi & Faruqi, LLP
Published: July 08, 2025 by: PRNewsWire
Sentiment: Neutral
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Elevance To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $100,000 in Elevance between April 18, 2024 and October 16, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , July 8, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Elevance Health, Inc. ("Elevance" …
Read More
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Elevance Health, Inc. of Class Action Lawsuit and Upcoming Deadlines - ELV
Published: July 07, 2025 by: PRNewsWire
Sentiment: Neutral
NEW YORK , July 7, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Elevance Health, Inc. ("Elevance" or the "Company") (NYSE: ELV). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
Read More
Elevance Health, Inc. (ELV) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
Published: July 07, 2025 by: PRNewsWire
Sentiment: Neutral
LOS ANGELES , July 7, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Elevance Health, Inc. ("Elevance" or the "Company") (NYSE: ELV) have opportunity to lead the securities fraud class action lawsuit.
Read More
ELV SHAREHOLDERS: The Elevance Health, Inc. July 11 Class Action Deadline is Approaching -- Contact BFA Law if You Suffered Losses (NYSE:ELV)
Published: July 04, 2025 by: GlobeNewsWire
Sentiment: Neutral
$ELV, ELV, Elevance Health, Invest, Drop, Class Action, Shareholder, Investigation, Investor, Lawsuit, Stock, BFA Law, BFA LLP, Bleichmar Fonti & Auld, Law
Read More
Elevance Health (NYSE: ELV) Deadline Approaching: Berger Montague Advises Investors of Deadline in Securities Fraud Lawsuit
Published: July 03, 2025 by: GlobeNewsWire
Sentiment: Neutral
PHILADELPHIA, July 03, 2025 (GLOBE NEWSWIRE) -- Berger Montague PC advises investors that a securities class action lawsuit has been filed against Elevance Health, Inc. (“Elevance” or the “Company”) (NYSE: ELV) on behalf of purchasers of Elevance securities between April 18, 2024 through October 16, 2024, inclusive (the “Class Period”).
Read More
ELV DEADLINE: ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Elevance Health, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important July 11 Deadline in Securities Class Action – ELV
Published: July 02, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, July 02, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Elevance Health, Inc. (NYSE: ELV) between April 18, 2024 and October 16, 2024, both dates inclusive (the “Class Period”), of the important July 11, 2025 lead plaintiff deadline.
Read More
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Elevance Health
Published: July 02, 2025 by: GlobeNewsWire
Sentiment: Neutral
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Elevance To Contact Him Directly To Discuss Their Options
Read More
ELV Investors Have Opportunity to Lead Elevance Health, Inc. Securities Fraud Lawsuit with the Schall Law Firm
Published: July 02, 2025 by: PRNewsWire
Sentiment: Neutral
LOS ANGELES , July 2, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Elevance Health, Inc. ("Elevance" or "the Company") (NYSE: ELV) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between April 18, 2024 and October 16, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before July 11, 2025.
Read More
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Elevance Health, Inc. of Class Action Lawsuit and Upcoming Deadlines - ELV
Published: July 02, 2025 by: PRNewsWire
Sentiment: Neutral
NEW YORK , July 2, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Elevance Health, Inc. ("Elevance" or the "Company") (NYSE: ELV). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
Read More
About Elevance Health Inc. (ELV)
- IPO Date 2001-10-30
- Website https://www.elevancehealth.com
- Industry Medical - Healthcare Plans
- CEO Gail Koziara Boudreaux
- Employees 104200